Last updated on November 2019

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)


Brief description of study

The aim of the study is to evaluate efficacy and safety of empagliflozin versus placebo on top of guideline-directed medical therapy in patients with heart failure with preserved ejection fraction

Clinical Study Identifier: NCT03057951

Find a site near you

Start Over

Yamamoto Clinic

Kanagawa, Sagamihara, Japan
2.69miles
  Connect »